WUP0 Stock Overview
An investment holding company, engages in the manufacture, marketing, and sale of branded prescription and non-prescription drugs, as well as Chinese pharmaceutical products in the People’s Republic of China and Hong Kong.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Sanai Health Industry Group Company Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.025 |
| 52 Week High | HK$0.23 |
| 52 Week Low | HK$0.013 |
| Beta | -0.25 |
| 11 Month Change | 100.00% |
| 3 Month Change | 100.00% |
| 1 Year Change | -80.00% |
| 33 Year Change | n/a |
| 5 Year Change | -37.50% |
| Change since IPO | -99.44% |
Recent News & Updates
Recent updates
Shareholder Returns
| WUP0 | DE Pharmaceuticals | DE Market | |
|---|---|---|---|
| 7D | 0% | 2.1% | 1.9% |
| 1Y | -80.0% | -15.3% | 5.3% |
Return vs Industry: WUP0 underperformed the German Pharmaceuticals industry which returned -15.9% over the past year.
Return vs Market: WUP0 underperformed the German Market which returned 5% over the past year.
Price Volatility
| WUP0 volatility | |
|---|---|
| WUP0 Average Weekly Movement | 273.9% |
| Pharmaceuticals Industry Average Movement | 5.3% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 11.0% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: WUP0's share price has been volatile over the past 3 months.
Volatility Over Time: WUP0's weekly volatility has increased from 185% to 274% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2006 | 68 | n/a | www.1889hk.com |
Sanai Health Industry Group Company Limited, an investment holding company, engages in the manufacture, marketing, and sale of branded prescription and non-prescription drugs, as well as Chinese pharmaceutical products in the People’s Republic of China and Hong Kong. It operates through three segments: Pharmaceutical Products, Finance Leasing, and Genetic Testing and Molecular Diagnostic Services. The company also engages in development, manufacturing, marketing, and sale of pharmaceutical products; sale of pharmaceutical related software; and provision of consultancy services.
Sanai Health Industry Group Company Limited Fundamentals Summary
| WUP0 fundamental statistics | |
|---|---|
| Market cap | €5.74m |
| Earnings (TTM) | €2.37m |
| Revenue (TTM) | €15.51m |
2.4x
P/E Ratio0.4x
P/S RatioIs WUP0 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| WUP0 income statement (TTM) | |
|---|---|
| Revenue | CN¥122.10m |
| Cost of Revenue | CN¥86.97m |
| Gross Profit | CN¥35.13m |
| Other Expenses | CN¥16.50m |
| Earnings | CN¥18.63m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Aug 30, 2024
| Earnings per share (EPS) | 0.12 |
| Gross Margin | 28.77% |
| Net Profit Margin | 15.26% |
| Debt/Equity Ratio | 22.6% |
How did WUP0 perform over the long term?
See historical performance and comparison